USFDA gives tentative nod to Alembic Pharma for Dasatinib tablets

Chronic, accelerated or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib.

300
USFDA Approval
USFDA Approval

Last Updated on October 15, 2024 by The Health Master

Alembic Pharma has received tentative approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Dasatinib tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg.

The tentatively approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Sprycel tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, of Bristol Myers Squibb Company (BMS).

Dasatinib tablet is indicated for the treatment of adult patients with newly-diagnosed Philadelphia chromosome-positive (Ph+) Chronic Myeloid Leukemia (CML) in chronic phase.

Chronic, accelerated or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib.

Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy.

USFDA gives final approval for Adapalene and Benzoyl Peroxide Topical Gel

USFDA gives approval for Leuprolide Acetate Injection

USFDA gives final nod to Zydus for Famotidine tablets

Indian Pharma Companies hiring former USFDA officers

USFDA withdraws approval for TG Therapeutics Cancer treatment

USFDA gives approval for generic Ibuprofen oral suspension

CDSCO classifies 214 Medical Devices under Medical Devices Rule, 2017

 PCI: Pharmacy Council of India is against e-selling of medicines

USFDA gives final approval for Adapalene and Benzoyl Peroxide Topical Gel

FDA Haryana and police raid, consignment of medicines recovered

Drug recall: 2.1 million doses of medicine recalled due to this reason

Rs 1050 per unit for Whole Blood, SBTC has fixed the maximum prices of Blood and its components

USFDA gives approval for Leuprolide Acetate Injection

Wrong Blood Transfusion resulting in death, a case of Medical Negligence: NCDRC

DCGI directs all Blood Centres to register on e-RaktKosh

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news